期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Loss of heterozygosity on chromosome 10q22-10q23 and 22q 11.2-22q 12.1 and p53gene in primary hepatocellular carcinoma 被引量:3
1
作者 Guang-NengZhu LiZuo +4 位作者 QingZhou Su-MeiZhang Hua-QingZhu shu-yugui YuanWang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第13期1975-1978,共4页
AIM: To analyze loss of heterozygosity (LOH) and homozygous deletion on p53 gene (exon2-3, 4 and 11), chromosome 10q22-10q23 and 22q11.2 -22q12.1 in human hepatocellular carcinoma (HCC).METHODS: PCR and PCR-based micr... AIM: To analyze loss of heterozygosity (LOH) and homozygous deletion on p53 gene (exon2-3, 4 and 11), chromosome 10q22-10q23 and 22q11.2 -22q12.1 in human hepatocellular carcinoma (HCC).METHODS: PCR and PCR-based microsatellite polymorphism analysis techniques were used.RESULTS: LOH was observed at D10S579 (10q22-10q23) in 4 of 20 tumors (20%), at D22S421 (22q11.2-22q12.1) in 3 of 20(15%), at TP53.A (p53gene exon 2-3) in 4 of 20 (20%), at TP53.B (p53gene exon 4) in 6 of 20(30%), and at TP53.G (p53gene exon 11)in 0 of 20(0%). Homozygous deletion was detected at 10q22-10q23(8/20; 40%), 22q11.2-22q12.1(8/20; 40%), p53 gene exon 2-3(0/20;0%), p53gene exon 4(6/20; 30%), and p53gene exon 11(2/20; 10%).CONCLUSION: There might be unidentified tumor suppressor genes on chromosome 10q22-10q23 and 22q11.2-22q12.1 that contribute to the pathogenesis and development of HCC. 展开更多
关键词 杂合性 丢失基因 染色体 10q22-10q23 22q11.2-22q12.1 P53 肝细胞癌 肿瘤 LOH
暂未订购
Distribution and expression of non-muscle myosin light chain kinase in rabbit livers 被引量:3
2
作者 Hua-QingZhu YuanWang +4 位作者 Ruo-LeiHu BinRen QingZhou Zhi-KuiJiang shu-yugui 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第12期2715-2719,共5页
AIM: To study the distribution and expression of non-muscle myosin light chain kinase (nmMLCK) in rabbit livers.METHODS: Human nmMLCK N-terminal cDNA was amplified by polymerase chain reaction (PCR) and was inserted i... AIM: To study the distribution and expression of non-muscle myosin light chain kinase (nmMLCK) in rabbit livers.METHODS: Human nmMLCK N-terminal cDNA was amplified by polymerase chain reaction (PCR) and was inserted into pBKcmv to construct expression vectors. The recombinant plasmid was transformed into XL1-blue. Expression protein was induced by IPTG and then purified by SDS-PAGE and electroelution, which was used to prepare the polycolonal antibody to detect the distribution and expression of nmMLCK in rabbit livers with immunofluorescene techniques.RESULTS: The polyclonal antibody was prepared, by which nmMLCK expression was detected and distributed mainly in peripheral hepatocytes.CONCLUSION: nmMLCK can express in hepatocytes peripherally, and may play certain roles in the regulation of hepatic functions. 展开更多
关键词 非肌浆球蛋白轻链酶 分布特征 肝脏 动物实验 PCR 多克隆抗体
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部